Company / Depreciation & Amortization
Integra Lifesciences Holdings Depreciation & Amortization History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$109.5M
FY2019
5-year range
-
FY2016-FY2019
Trend
-1.1%
vs FY2018
Sector context
#64 of 141
Health Care
What the data says
At $109M, Integra Lifesciences Holdings's depreciation & amortization ranks #78 of 141 in the Health Care sector. Increased from $59M to $109M over the past 2 years.
Based on SEC 10-K filings.
$109M in FY2019 with a 3-year CAGR of +33.1%.
Increased from $59M to $109M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +33.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#78 of 141 in Health CareTop 55% of 141This company $109.5M Sector average $344.6M
▼
-68.2% below sector average
Key checks
Key Insights
- 3-year CAGR of +33.1%, indicating consistent growth.
- In FY2019, depreciation & amortization decreased 1.1% year-over-year.
- Ranks #64 out of 141 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $109.5M | -1.1% |
| FY2018 | $110.7M | +88.1% |
| FY2017 | $58.9M | +26.8% |
| FY2016 | $46.4M | -21.1% |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026